Adequan Canine
Licensed U.S. Pharmacy | Pharmacy Verified

Adequan Canine

Item#
FREE SHIPPING Over $39! * Pet Food & Other Exclusions
1. Select count:
QTY:-+
Recurring Saings in EprxAUTOSHIP & SAVE[Details]
$65.90Reg $85.99
$130.99Reg $170.99

Related Items

  • Description
  • Directions
  • Reviews

Description

Adequan Injectable for Dogs is an injectable medication prescribed to help manage arthritis and joint problems in dogs. It may also help restore joint lubrication, relieve inflammation and renew the foundation of healthy cartilage. For over 20 years, this medication has been prescribed and trusted by veterinarians to help moderate signs connected with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

Adequan is recommended for the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in dogs.

Prescription Required

Directions

Practice aseptic techniques in withdrawing each dose to decrease the possibility of post-injection bacterial infections. Adequately clean and disinfect the stopper prior to entry with a sterile needle and syringe. Use only sterile needles, and use each needle only once.

View Adequan Drug Facts Sheet.

The vial stopper may be punctured a maximum of 10 times.

The recommended dose of Adequan® Canine is 2 mg/lb body weight (.02 mL/lb, or 1 mL per 50 lb), by intramuscular injection only, twice weekly for up to 4 weeks (maximum of 8 injections). Do not exceed the recommended dose or therapeutic regimen. Do not mix Adequan® Canine with other drugs or solvents.

Contraindications: Do not use in dogs showing hypersensitivity to PSGAG. PSGAG is a synthetic heparinoid; do not use in dogs with known or suspected bleeding disorders.

Precautions: The safe use of Adequan® Canine used in breeding, pregnant, or lactating dogs has not been evaluated. Use with caution in dogs with renal or hepatic impairment.

Adverse Reactions: In the clinical efficacy trial, 24 dogs were treated with Adequan ® Canine twice weekly for 4 weeks. Possible adverse reactions were reported after 2.1% of the injections. These included transient pain at the injection site (1 incident), transient diarrhea (1 incident each in 2 dogs), and abnormal bleeding (1 incident). These effects were mild and self-limiting and did not require interruption of therapy

Warnings: Not for use in humans. Keep this and all medications out of reach of children.

Storage Conditions: Store at 20° to 25°C (68° to 77°F) excursions permitted to 15° to 30°C (59° to 86°F) (See USP Controlled Room Temperature). Avoid prolonged exposure to temperatures ≥ 40°C (104°F).

Use within 28 days of first puncture and puncture a maximum of 10 times. Dispose of spent needles in accordance with all federal, state and local environmental laws